1. Brainware University Digital Repository
  2. Serial Abstracting Service
  3. Journal & Magazine Article Abstracts
  4. Indian Journal of Medical Research
  5. Vol. 163, No.4, 2026
Please use this identifier to cite or link to this item: http://111.93.178.142:25000/jspui/handle/123456789/5639
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNaveen Bhagat-
dc.date.accessioned2026-07-08T09:49:00Z-
dc.date.available2026-07-08T09:49:00Z-
dc.date.issued2026-07-08-
dc.identifier.urihttp://111.93.178.142:25000/jspui/handle/123456789/5639-
dc.descriptionVol. 463, No. 4, p 477en_US
dc.language.isoenen_US
dc.subjectInsulin resistanceen_US
dc.subjectNAFLDen_US
dc.subjectNon Alcoholic Fatty Live Diseaseen_US
dc.subjectMetalic dysfunction -Associated Steatotic Liver Diseaseen_US
dc.subjectSaroglitazaren_US
dc.titleSaroglitazar for non-obese metabolic - dysfunction associated steatotic liver diseas (MASLD): An open label randomised controlled trialen_US
dc.typeOtheren_US
Appears in Collections:Vol. 163, No.4, 2026

Files in This Item:
File Description SizeFormat 
1.pdfVol. 463, No. 4, p 477209.09 kBAdobe PDFView/Open
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.